Internal Medicine, Gastroenterology · New York, NY
NPI
1730349218
Since 2008
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
5 E 98th St
New York, NY, 10029
Phone (212) 241-4299
Groups this clinician bills Medicare through
Medicare paid, 2024
$393K
15,794 services
Medicare patients, 2024
598
Average age 76
Drug cost, 2024
$1.5M
1,123 prescriptions
Company payments, 2025
$47K
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Steven Naymagon was code J3380 (injection, vedolizumab, intravenous, 1 mg), 11,700 times for 11 patients. In total Steven Naymagon billed 15,794 services in 45 codes, and Medicare paid $393K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3380 Injection, vedolizumab, intravenous, 1 mg | Office | 11,700 | 11 | $17.49 | $205K |
| 99213 Office E&M - Established | Office | 263 | 198 | $76.94 | $20K |
| 99204 Office E&M - New | Office | 161 | 161 | $140.14 | $23K |
| 99214 Office E&M - Established | Office | 158 | 130 | $109.15 | $17K |
| 45380 Lower GI Endoscopy - Other | Facility | 124 | 123 | $109.11 | $14K |
| 43239 Upper GI Endoscopy | Facility | 104 | 102 | $94.91 | $9,871 |
| 45385 Colonoscopy - Lesion Removal | Facility | 82 | 81 | $231.68 | $19K |
| 99203 Office E&M - New | Office | 72 | 72 | $76.54 | $5,511 |
| G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 57 | 40 | $11.91 | $679 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 54 | 14 | $0.51 | $27.69 |
| 96365 Intravenous Infusion, Hydration | Office | 42 | 12 | $55.79 | $2,343 |
| 91110 Standard X-ray | Office | 24 | 21 | $656.83 | $16K |
| 45378 Lower GI Endoscopy - Other | Facility | 21 | 20 | $169.84 | $3,567 |
| 43235 Upper GI Endoscopy | Facility | 15 | 15 | $90.69 | $1,360 |
| 45381 Lower GI Endoscopy - Other | Facility | 12 | 12 | $13.85 | $166 |
By year: 2022 $178K for 1,847 services; 2023 $183K for 3,674 services; 2024 $393K for 15,794 services.
Medicare prescription drug claims, 2024
In 2024, the drug Steven Naymagon prescribed most often to Medicare patients was Famotidine, with 159 prescriptions and refills. In total Steven Naymagon wrote 1,123 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 159 | 323 | 54 | $2,808 |
| Omeprazole Generic | 113 | 167 | 40 | $1,113 |
| Pantoprazole Sodium Generic | 65 | 109 | 23 | $896 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 60 | 60 | 55 | $10K |
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 47 | 47 | 41 | $711 |
| Mesalamine Generic | 45 | 64 | 13 | $19K |
| Linzess Linaclotide | 37 | 65 | 11 | $32K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 27 | 27 | 27 | $1,801 |
| Budesonide Dr Budesonide | 22 | 22 | Under 11 | $1,053 |
| Ondansetron Odt Ondansetron | 20 | 22 | Under 11 | $331 |
| Stelara Ustekinumab | 19 | 29 | Under 11 | $453K |
| Dicyclomine Hcl Generic | 18 | 24 | Under 11 | $258 |
| Sucralfate Generic | 16 | 17 | Under 11 | $2,506 |
| Enulose Lactulose | 15 | 15 | Under 11 | $118 |
| Sutab Sod Sulf/Pot Chloride/Mag Sulf | 15 | 15 | 15 | $2,396 |
Brand drugs: - claims; generic drugs: 772 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven Naymagon $47K ($47K in general payments such as food, travel and fees) from 19 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $41K.
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 66 | $41K |
| Abbvie Inc. ABBV | 90 | $1,556 |
| Janssen Biotech, Inc. JNJ | 45 | $1,214 |
| Janssen Scientific Affairs, LLC JNJ | 4 | $580 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 45 | $433 |
| QOL Medical, LLC | 7 | $301 |
| Lilly USA, LLC LLY | 13 | $172 |
| Ardelyx, Inc. ARDX | 11 | $168 |
| Aimmune Therapeutics, Inc. | 15 | $137 |
| Sandoz Inc. SDZ.SW | 5 | $132 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.